LeMaitre Vascular/LMAT

$79.75

0.21%
-
1D1W1MYTD1YMAX

About LeMaitre Vascular

LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Its portfolio of product lines is primarily used to treat vascular disease, of which most are used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy catheters, occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. The Company’s principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. The Company sells its products and services primarily through a direct sales force.

Ticker

LMAT

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

George Lemaitre

Employees

614

Headquarters

Burlington, United States

LMAT Metrics

BasicAdvanced
$1.8B
Market cap
52.84
P/E ratio
$1.51
EPS
0.89
Beta
$0.56
Dividend rate
0.8%
Dividend yield
$1.8B
0.89192
$81.68
$44.27
139K
$0.56
7.57
5.311
38.11%
69.914
10.15%
11.65%
10.99%
52.837
8.955
5.802
8.848
89.059
0.94%
0.7%
0.8%
18.16%
62.54%
14.36%
9.02%
13.78%

What the Analysts think about LMAT

Analyst Ratings

Majority rating from 9 analysts.
Buy

Price Targets

Average projection from 8 analysts.
5.33% downside
High $90.00
Low $54.00
$79.75
Current price
$75.50
Average price target

LMAT Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
18.35% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$53M
9.43%
Net income
$9.8M
16.67%
Profit margin
18.35%
6.62%

LMAT Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 13.62%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.36
$0.33
$0.38
$0.44
-
Expected
$0.32
$0.30
$0.36
$0.39
$0.47
Surprise
13.77%
9.09%
6.38%
13.62%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for LeMaitre Vascular stock?

LeMaitre Vascular (LMAT) has a market cap of $1.8B as of May 28, 2024.

What is the P/E ratio for LeMaitre Vascular stock?

The price to earnings (P/E) ratio for LeMaitre Vascular (LMAT) stock is 52.84 as of May 28, 2024.

Does LeMaitre Vascular stock pay dividends?

Yes, the LeMaitre Vascular (LMAT) stock pays dividends to shareholders. As of May 28, 2024, the dividend rate is $0.56 and the yield is 0.8%. LeMaitre Vascular has a payout ratio of 38.11% on a trailing twelve-month basis.

When is the next LeMaitre Vascular dividend payment date?

The next LeMaitre Vascular (LMAT) dividend payment is scheduled for May 30, 2024.

What is the beta indicator for LeMaitre Vascular?

LeMaitre Vascular (LMAT) has a beta rating of 0.89. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the LeMaitre Vascular stock price target?

The target price for LeMaitre Vascular (LMAT) stock is $75.5, which is 5.33% below the current price of $79.75. This is an average based on projections from 8 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell LeMaitre Vascular stock

Buy or sell LeMaitre Vascular stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing